|
|
|
Scientists from
the Kyoto Prefectural University of Medicine, Japan (sponsored by Fuji
Chemical Industry) confirmed that astaxanthin significantly suppressed ROS
production, biomarkers of oxidative damage and proinflammatory responses in
mitochondria of Normal Human Mesangial Cells (NHMC) exposed to high-levels of
glucose. |
|
|
|
NHMCs pre-incubated with astaxanthin reduced the inflammatory response. For example, NF-kB activation and subsequent movement to the cell nucleus for inflammatory gene activation was inhibited (Figure 3). Astaxanthin also reduced AP-1 activation and expression/production of COX-2, MCP-1, and TGFB1. If not suppressed, these factors will promote the pathogenesis and mesangial cell injury. |
Although the mechanism by which astaxanthin suppresses ROS has to be further investigated, the researchers postulated that astaxanthin may affect part of the electron transport chain and protect mitochondria from the detrimental effects of glucose toxicity In summary, astaxanthin may scavenge excess ROS, reduce ROS-protein damage, and inhibit inflammatory process. Therefore, the onset of nephropathy may expect to be prevented or delayed. Globally, Diabetes Mellitus and its complications is the third largest killer (WHO 1995). At the current rate, the diabetic population of 171 million will increase to 366 million by 2030. One of the most common complications associated with DM is nephropathy or kidney damage. In a separate study, randomized glycemic control reduced or normalized mitochondrial ROS production and delayed the onset and progression of early stage diabetic complications. Furthermore, previous studies sponsored by Fuji Chemical Industry showed that astaxanthin reduced kidney damage in diabetic mouse models and many other biomarkers (reduced DNA damage, improved glucose-tolerance test, lowered NF-kB). Even though the previous studies demonstrated that astaxanthin could suppress ROS and reduce nephropathy, the mechanism remained unclear to how astaxanthin could reduce renal damage until now. |
Reference: Manabe et al., 2007. Astaxanthin protects
mesangial cells from hyperglycemia-induced oxidative signaling. Journal of
Cellular Biochemistry Online Publication 22 Oct 2007. |
Fuji Chemical
Industry, |
For more
information, please contact us.
If you would prefer not to receive email newsletter, or you’ve changed
your email address, please click here |